Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.0536
+0 (+0%)
At Close: Apr 15, 2020
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Feb 05, 2019 $0.0800 $0.0800 $0.0680 $0.0710 41 279
Feb 04, 2019 $0.0899 $0.0899 $0.0680 $0.0740 15 437
Feb 01, 2019 $0.0461 $0.0899 $0.0461 $0.0899 21 024
Jan 31, 2019 $0.0461 $0.0800 $0.0461 $0.0800 6 302
Jan 30, 2019 $0.0631 $0.0790 $0.0631 $0.0790 6 213
Jan 29, 2019 $0.0800 $0.0800 $0.0800 $0.0800 79
Jan 28, 2019 $0.0451 $0.0900 $0.0451 $0.0800 10 962
Jan 25, 2019 $0.0900 $0.0900 $0.0453 $0.0900 6 891
Jan 24, 2019 $0.0450 $0.105 $0.0402 $0.0980 22 598
Jan 23, 2019 $0.0450 $0.0700 $0.0450 $0.0700 17 955
Jan 22, 2019 $0.0600 $0.0700 $0.0450 $0.0700 25 578
Jan 18, 2019 $0.0451 $0.0700 $0.0402 $0.0596 7 684
Jan 17, 2019 $0.0391 $0.0700 $0.0390 $0.0700 51 965
Jan 16, 2019 $0.0700 $0.0700 $0.0390 $0.0600 10 585
Jan 15, 2019 $0.0640 $0.0700 $0.0390 $0.0700 7 010
Jan 14, 2019 $0.0380 $0.0680 $0.0380 $0.0680 19 446
Jan 11, 2019 $0.0680 $0.0680 $0.0680 $0.0680 148
Jan 10, 2019 $0.0350 $0.0680 $0.0350 $0.0680 1 112
Jan 09, 2019 $0.0350 $0.0700 $0.0350 $0.0700 6 538
Jan 08, 2019 $0.0600 $0.0700 $0.0350 $0.0700 187 617
Jan 07, 2019 $0.0450 $0.0620 $0.0450 $0.0620 106 837
Jan 04, 2019 $0.0500 $0.0535 $0.0400 $0.0450 54 465
Jan 03, 2019 $0.0500 $0.0500 $0.0450 $0.0500 26 393
Jan 02, 2019 $0.0250 $0.0620 $0.0250 $0.0600 25 576
Dec 31, 2018 $0.0265 $0.0600 $0.0250 $0.0300 89 572
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT